Literature DB >> 30531800

Evaluation of episcleral venous fluid wave during gonioscopy assisted transluminal trabeculotomy in patients with advanced glaucoma.

Zeynep Aktas1, M Cuneyt Ozmen2, H Tuba Atalay2, A Yucel Ucgul2.   

Abstract

PURPOSE: To evaluate episcleral venous fluid wave (EVFW) during GATT surgery in patients with advanced stage open angle glaucoma and to investigate its relationship with the severity of glaucoma.
METHODS: In all, 34 eyes of 28 open angle glaucoma patients who underwent GATT surgery were included into study. The extent of EVFW was evaluated using surgical records of patients and it was defined as number of clock hours. Correlations between the extent of EVFW and GAAT surgical outcomes as determined by intraocular pressures (IOP) and postoperative antiglaucoma medication needs were investigated. The impact of preoperative maximum IOP on EVFW was also evaluated.
RESULTS: There was a significant correlation between IOPs and the extent of the EVFW at 1st, 3rd, 6th and 12th months follow-up visits. 10 of (%29.4) 34 eyes required antiglaucoma medications after the surgery. Mean extents of EVFW in patients who needed and did not need medications during follow-ups were 2.6 ± 1.0 (1-4) and 5.9 ± 1.5 (3-8) clock hours and the difference was statistically significant. Cutoff value of <4.5 clock hours for the EVFW (sensitivity 79.2%, specifity 100%) was found to be associated with the need for additional antiglaucoma medication.
CONCLUSIONS: The extent of EVFW might be a valuable prognostic indicator for the surgical success of GATT since trabeculotomy is circumferential in this surgical technique making all collector channels accessible.

Entities:  

Mesh:

Year:  2018        PMID: 30531800      PMCID: PMC6461941          DOI: 10.1038/s41433-018-0254-5

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  12 in total

Review 1.  Micro-invasive glaucoma surgery: current perspectives and future directions.

Authors:  Hady Saheb; Iqbal Ike K Ahmed
Journal:  Curr Opin Ophthalmol       Date:  2012-03       Impact factor: 3.761

2.  Clinical results of ab interno trabeculotomy using the trabectome for open-angle glaucoma: the Mayo Clinic series in Rochester, Minnesota.

Authors:  Yachna Ahuja; Son Ma Khin Pyi; Mehrdad Malihi; David O Hodge; Arthur J Sit
Journal:  Am J Ophthalmol       Date:  2013-08-15       Impact factor: 5.258

3.  Episcleral Venous Fluid Wave Correlates with Trabectome Outcomes: Intraoperative Evaluation of the Trabecular Outflow Pathway.

Authors:  Ronald L Fellman; William J Feuer; Davinder S Grover
Journal:  Ophthalmology       Date:  2015-10-21       Impact factor: 12.079

4.  Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.

Authors:  Steven J Gedde; Joyce C Schiffman; William J Feuer; Leon W Herndon; James D Brandt; Donald L Budenz
Journal:  Am J Ophthalmol       Date:  2012-01-15       Impact factor: 5.258

5.  Gonioscopy-assisted transluminal trabeculotomy, ab interno trabeculotomy: technique report and preliminary results.

Authors:  Davinder S Grover; David G Godfrey; Oluwatosin Smith; William J Feuer; Ildamaris Montes de Oca; Ronald L Fellman
Journal:  Ophthalmology       Date:  2014-01-10       Impact factor: 12.079

6.  Gonioscopy-assisted Transluminal Trabeculotomy (GATT): Thermal Suture Modification With a Dye-stained Rounded Tip.

Authors:  Davinder S Grover; Ronald L Fellman
Journal:  J Glaucoma       Date:  2016-06       Impact factor: 2.503

7.  Anatomic changes in Schlemm's canal and collector channels in normal and primary open-angle glaucoma eyes using low and high perfusion pressures.

Authors:  Cheryl R Hann; Andrew J Vercnocke; Michael D Bentley; Steven M Jorgensen; Michael P Fautsch
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-19       Impact factor: 4.799

8.  Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract.

Authors:  Thomas W Samuelson; L Jay Katz; Jeffrey M Wells; Yi-Jing Duh; Jane Ellen Giamporcaro
Journal:  Ophthalmology       Date:  2010-09-15       Impact factor: 12.079

9.  Gonioscopy assisted transluminal trabeculotomy: an ab interno circumferential trabeculotomy for the treatment of primary congenital glaucoma and juvenile open angle glaucoma.

Authors:  Davinder S Grover; Oluwatosin Smith; Ronald L Fellman; David G Godfrey; Michelle R Butler; Ildamaris Montes de Oca; William J Feuer
Journal:  Br J Ophthalmol       Date:  2015-02-12       Impact factor: 4.638

10.  Trabectome surgery for primary and secondary open angle glaucomas.

Authors:  Jens F Jordan; Thomas Wecker; Christian van Oterendorp; Alexandra Anton; Thomas Reinhard; Daniel Boehringer; Matthias Neuburger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-26       Impact factor: 3.117

View more
  10 in total

1.  Gonioscopy-assisted transluminal trabeculotomy in primary angle-closure glaucoma.

Authors:  Eamon Sharkawi; Paul H Artes; Daniel Josef Lindegger; Maria Laura Dari; Mohamad El Wardani; Jérôme Pasquier; Adriano Guarnieri
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-06-22       Impact factor: 3.117

2.  The efficacy of gonioscopy-assisted transluminal trabeculectomy combined with phacoemulsification.

Authors:  Ercüment Bozkurt; Fatih Yenihayat; Ali Olgun; Ahmet Taylan Yazıcı; İbrahim Şahbaz
Journal:  Int Ophthalmol       Date:  2020-08-31       Impact factor: 2.031

3.  Outcomes of Combined Prolene Gonioscopy Assisted Transluminal Trabeculotomy with Phacoemulsification in Open-Angle Glaucoma.

Authors:  Waldo Loayza-Gamboa; Vladimir Martel-Ramirez; Vanessa Inga-Condezo; Vanessa Valderrama-Albino; Rosa Alvarado-Villacorta; Diego Valera-Cornejo
Journal:  Clin Ophthalmol       Date:  2020-10-02

4.  Efficacy comparison of combined trabeculectomy with MMC and gonioscopy-assisted transluminal trabeculotomy.

Authors:  Ali Olgun; Hacı Ugur Celik; Fatih Yenihayat; Ercument Bozkurt; İbrahim Sahbaz
Journal:  Int Ophthalmol       Date:  2022-01-28       Impact factor: 2.031

5.  Twelve-Month Outcomes of Stand-Alone Excisional Goniotomy in Mild to Severe Glaucoma.

Authors:  Mohammed K ElMallah; John P Berdahl; Blake K Williamson; Syril K Dorairaj; Malik Y Kahook; Mark J Gallardo; Ahad Mahootchi; Sanjay N Smith; Leonard A Rappaport; Daniela Diaz-Robles; Gabriel S Lazcano-Gomez
Journal:  Clin Ophthalmol       Date:  2020-07-03

6.  Outcomes of gonioscopy-assisted transluminal trabeculotomy in pseudoexfoliative glaucoma: 24-month follow-up.

Authors:  Eamon Sharkawi; Adriano Guarnieri; Daniel Josef Lindegger; Paul H Artes; Lydia Lehmann-Clarke; Mohamad El Wardani; Marie Misteli; Jérôme Pasquier
Journal:  Br J Ophthalmol       Date:  2020-07-29       Impact factor: 4.638

Review 7.  Minimally Invasive Glaucoma Surgery: What Do We Know? Where Should We Go?

Authors:  Chen Xin; Huangzhou Wang; Ningli Wang
Journal:  Transl Vis Sci Technol       Date:  2020-04-23       Impact factor: 3.283

8.  Canaloplasty and Trabeculotomy Combined with Phacoemulsification in Open-Angle Glaucoma: Interim Results from the GEMINI Study.

Authors:  Mark J Gallardo; Steven R Sarkisian; Steven D Vold; Inder Paul Singh; Brian E Flowers; Anita Campbell; Kavita Dhamdhere; Thomas W Samuelson
Journal:  Clin Ophthalmol       Date:  2021-02-10

9.  Canaloplasty and Trabeculotomy Combined with Phacoemulsification for Glaucoma: 12-Month Results of the GEMINI Study.

Authors:  Mark J Gallardo; Mark F Pyfer; Steven D Vold; Steven R Sarkisian; Anita Campbell; Inder Paul Singh; Brian Flowers; Kavita Dhamdhere
Journal:  Clin Ophthalmol       Date:  2022-04-21

10.  12-month interim results of a prospective study of patients with mild to moderate open-angle glaucoma undergoing combined viscodilation of Schlemm's canal and collector channels and 360° trabeculotomy as a standalone procedure or combined with cataract surgery.

Authors:  Iwona Grabska-Liberek; Patrycja Duda; Monika Rogowska; Julita Majszyk-Ionescu; Agnieszka Skowyra; Anna Koziorowska; Ingrid Kane; Jaroslaw Chmielewski
Journal:  Eur J Ophthalmol       Date:  2021-02-24       Impact factor: 2.597

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.